|
Sep 30
|
Investor Alert and Limitation Period: Canadian investors that purchased shares of Bausch Health Companies, Inc. listed on the Toronto Stock Exchange need to act
|
|
Sep 28
|
Bausch Health Companies Inc. (BHC): A Top Pick in Carl Icahn’s Stock Portfolio
|
|
Aug 20
|
Bausch Health Companies Inc. (BHC): One of the Best Canadian Stocks Under $20
|
|
Jul 25
|
Bausch Health (BHC) Earnings Expected to Grow: Should You Buy?
|
|
Jul 24
|
Bausch Health Stock Swings Wildly as it Addresses Report It's Considering Bankruptcy
|
|
Jul 24
|
Bausch Health Responds to Market Rumors
|
|
Jul 24
|
Bausch Health tanks 23.3% on unconfirmed report of bankruptcy filing
|
|
Jul 24
|
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 23
|
Nanotechnology in medicine: Who are the leading public companies?
|
|
Jun 20
|
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
|
|
Jun 16
|
With 63% ownership of the shares, Bausch Health Companies Inc. (NYSE:BHC) is heavily dominated by institutional owners
|
|
Jun 14
|
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
|
|
May 29
|
Bausch + Lomb’s enVista Envy IOL obtains Health Canada approval
|
|
May 23
|
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
|
|
Apr 8
|
CANADA STOCKS-TSX ends flat as gold stocks drop, mood cautious ahead of rate decision
|
|
Apr 8
|
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
|
|
Apr 8
|
BLCO vs. AVTR: Which Stock Is the Better Value Option?
|
|
Apr 5
|
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
|
|
Apr 3
|
/C O R R E C T I O N from Source -- Canadian Investment Regulatory Organization (CIRO) - Halts/Resumptions/
|
|
Apr 3
|
Here's Why Bausch Health (BHC) is a Strong Momentum Stock
|